Head and Neck Pathology

, Volume 9, Issue 4, pp 447–452 | Cite as

Giant Cell Tumor of the Larynx Treated by Surgery and Adjuvant Denosumab: Case Report and Review of the Literature

  • Aaron E. Yancoskie
  • Douglas K. Frank
  • John E. Fantasia
  • Steven Savona
  • Nicole Eiseler
  • Ilan Reder
  • Leonard B. Kahn
Original Paper


Giant cell tumor of the larynx (GCTL) is a rare entity; only 34 cases have been reported in the literature. We report a case of GCTL in a 46 year-old male presenting clinical, radiographic, histological and therapeutic features. Previously reported cases are also reviewed.


Giant cell Denosumab Head and neck surgery Larynx 


  1. 1.
    Dahlin DC, Cupps RE, Johnson EW. Giant-cell tumor: a study of 195 cases. Cancer. 1970;25(5):1061–70.CrossRefPubMedGoogle Scholar
  2. 2.
    Reid R, Banerjee SS, Sciot R. Giant cell tumours. In: Fletcher CDM, Unni KK, Mertens F, editors. World Health Organization classification of tumors. Pathology and genetics of tumors of soft tissue and bone. Lyon: IARC Press; 2002. p. 309–13.Google Scholar
  3. 3.
    Wieneke JA, Gannon FH, Heffner DK, Thompson LD. Giant cell tumor of larynx: a clinicopathologic series of eight cases and review of the literature. Mod Pathol. 2001;14(12):1209–15.CrossRefPubMedGoogle Scholar
  4. 4.
    Lau YS, Sabokbar A, Gibbons C, Giele H, Athanasou N. Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue. Hum Pathol. 2005;36(9):945–54.CrossRefPubMedGoogle Scholar
  5. 5.
    Werner JA, Harms D, Beigel A. Giant cell tumor of the larynx: case report and review of the literature. Head Neck. 1997;19(2):153–7.CrossRefPubMedGoogle Scholar
  6. 6.
    Wong KK, Seikaly H. Giant cell tumour of the larynx: case report and review of the literature. J Otolaryngol. 2004;33(3):195–7.CrossRefPubMedGoogle Scholar
  7. 7.
    Nishimura K, Satoh T, Maesawa C, Ishijima K, Sato H. Giant cell tumor of the larynx: a case report and review of the literature. Am J Otolaryngol. 2007;28(6):436–40.CrossRefPubMedGoogle Scholar
  8. 8.
    Nota J, Okochi Y, Watanabe F, Saiki T. Laryngeal giant cell tumor: a case report and review of the literature. Case Rep Otolaryngol. 2014;2014:5035947.Google Scholar
  9. 9.
    Coyas A, Anastassiades OT, Kyriakos I. Malignant giant cell tumour of the larynx. J Laryngol Otol. 1974;88(8):799–803.CrossRefPubMedGoogle Scholar
  10. 10.
    Hall-Jones J. Giant cell tumour of the larynx. J Laryngol Otol. 1972;86(04):371–81.CrossRefPubMedGoogle Scholar
  11. 11.
    Ribari O, Elemer G, Balint A. Laryngeal giant cell tumour. J Laryngol Otol. 1975;89(8):857–61.CrossRefPubMedGoogle Scholar
  12. 12.
    Murrell GL, Lantz HJ. Giant cell tumor of the larynx. Ear Nose Throat J. 1993;72(5):360–1.PubMedGoogle Scholar
  13. 13.
    Martin PC, Hoda SA, Pigman HT, Pulitzer DR. Giant cell tumor of the larynx: case report and review of the literature. Arch Pathol Lab Med. 1994;118(8):834–7.PubMedGoogle Scholar
  14. 14.
    Thomas DM, Wilkins MJ, Witana JS, Cook T, Jefferis AF, Walsh-Waring GP. Giant cell reparative granuloma of the cricoid cartilage. J Laryngol Otol. 1995;109(11):1120–3.CrossRefPubMedGoogle Scholar
  15. 15.
    Iype EM, Abraham EK, Kumar K, Pandey M, Prabhakar J, Ahamed MI, et al. Giant cell tumour of hyoid bone: case report. Br J Oral Maxillofac Surg. 2000;38(6):610–1.CrossRefPubMedGoogle Scholar
  16. 16.
    Hinni ML. Giant cell tumor of the larynx. Ann Otol Rhinol Laryngol. 2000;109(1):63–6.CrossRefPubMedGoogle Scholar
  17. 17.
    Rochanawutanon M, Praneetvatakul P, Laothamatas J, Sirikulchayanonta V. Extraskeletal giant cell tumor of the larynx: case report and review of the literature. Ear Nose Throat J. 2011;90(5):226–30.PubMedGoogle Scholar
  18. 18.
    Derbel O, Zrounba P, Chassagne-Clément C, Decouvelaere AV, Orlandini F, Duplomb S, et al. An unusual giant cell tumor of the thyroid: case report and review of the literature. J Clin Endocrinol Metab. 2013;98(1):1–6.CrossRefPubMedGoogle Scholar
  19. 19.
    Waldron CA, Shafer WG. The central giant cell reparative granuloma of the jaws. An analysis of 38 cases. Am J Clin Pathol. 1966;45(4):437–47.PubMedGoogle Scholar
  20. 20.
    Neville BW, Damm DD, Allen CM, Bouquot JE. Oral and maxillofacial pathology. 3rd ed. St. Louis: Saunders; 2008.Google Scholar
  21. 21.
    Liu B, Yu SF, Li TJ. Multinucleated giant cell in various forms of giant cell containing lesions of the jaws express features of osteoclasts. J Oral Pathol Med. 2003;32(6):367–75.CrossRefPubMedGoogle Scholar
  22. 22.
    Gonzales AL, Cates JMM. Osteosarcoma: differential diagnostic considerations. Surg Pathol Clin. 2012;5:117–46.CrossRefGoogle Scholar
  23. 23.
    Sciubba JJ, Fantasia JE, Kahn LB. Atlas of tumor pathology: tumors and cysts of the jaws, vol. 3. Washington: Armed Forces Institute of Pathology; 2001.Google Scholar
  24. 24.
    Mintz GA, Abrams AM, Carlsen GD, Melrose RJ, Fister HW. Primary malignant giant cell tumor of the mandible: report of a case and review of the literature. Oral Surg Oral Med Oral Pathol. 1981;51(2):164–71.CrossRefPubMedGoogle Scholar
  25. 25.
    Gomes CC, Diniz MG, Amaral FR, Guimaraes BVA, Gomez RS. The highly prevalent H3F3A mutation in giant cell tumours of bone is not shared by sporadic central giant cell lesions of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;118:583–5.CrossRefPubMedGoogle Scholar
  26. 26.
    Wang H, Wan N, Hu Y. Giant cell tumour of bone: a new evaluating system is necessary. Int Orthop. 2012;36(12):2521–7.PubMedCentralCrossRefPubMedGoogle Scholar
  27. 27.
    Chawla S, Henshaw R, Seeger L, Choy E, Blay JY, Ferrari S, et al. Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study. Lancet Oncol. 2013;14(9):901–8.CrossRefPubMedGoogle Scholar
  28. 28.
    Boyce BF, Xing L. Biology of RANK, RANKL, and osteoprotegrin. Arthritis Res Ther. 2007;9(Suppl 1):S1.PubMedCentralCrossRefPubMedGoogle Scholar
  29. 29.
    Bone HG, Chapurlat R, Brandi ML, Brown JP, Czerwinski E, Krieg MA, et al. The effect of three or six years of denosumab exposure in women with postmenopausal osteoporosis: results from the FREEDOM extension. J Clin Endocrinol Metab. 2013;98(11):4483–92.PubMedCentralCrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • Aaron E. Yancoskie
    • 1
  • Douglas K. Frank
    • 2
  • John E. Fantasia
    • 1
  • Steven Savona
    • 3
  • Nicole Eiseler
    • 4
  • Ilan Reder
    • 5
  • Leonard B. Kahn
    • 5
  1. 1.Division of Oral and Maxillofacial Pathology, Department of Dental MedicineHofstra North Shore-LIJ School of MedicineNew Hyde ParkUSA
  2. 2.Division of Head and Neck Surgery, Department of OtolaryngologyHofstra North Shore-LIJ School of MedicineNew Hyde ParkUSA
  3. 3.The Monter Cancer CenterHofstra School of MedicineLake SuccessUSA
  4. 4.Internal Med-Hematology OncHofstra North Shore-LIJ School of MedicineNew Hyde ParkUSA
  5. 5.Department of PathologyHofstra North Shore-LIJ School of MedicineNew Hyde ParkUSA

Personalised recommendations